Development of cyclic peptides that can be administered orally to inhibit disease targets
Crossref DOI link: https://doi.org/10.1038/s41589-023-01505-0
Published Online: 2023-12-28
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2023-12-28
Version of Record valid from 2023-12-28
Article History
First Online: 28 December 2023